Sonoma Pharmaceuticals, Inc.

SNOA

US83558L2043

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 01:20:09 17/07/2024 am IST			5-day change	1st Jan Change
0.402 ^USD	+3.18%		+39.75%	+118.46%

09/07	Sonoma Pharmaceuticals, Inc. Announces New Distributor in Ukraine	CI
17/06	Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Sonoma Pharmaceuticals, Inc. Announces New Distributor in Ukraine

July 09, 2024 at 05:00 pm IST

Sonoma Pharmaceuticals, Inc. announced that it is expanding its distributor base in Europe by adding a new partnership with Smart Healthcare Company (SHC) s.r.o. for the distribution of its Microdacyn60 wound care products into Ukraine.CH, based in Slovakia, will work with DANA MC, a leading supplier of the medical market in Ukraine, to distribute Sonoma's Microdacyn60 solution and hydrogel into this territory.

Latest news about Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. Announces New Distributor in Ukraine	09/07	CI
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	18/06	CI
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores	09/05	CI
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02	CI
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use	23/01	CI
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma?s Extensive Distributor Network	09/01	CI
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Sonoma Pharmaceuticals, Inc. Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation At the Symposium on Advanced Wound Care Fall Conference	03/11	CI
Sector Update: Health Care Stocks Ease in Late Afternoon	27/23/27	MT
Sector Update: Health Care	27/23/27	MT
Top MIdday Decliners	27/23/27	MT
Wall Street Set to Open Lower as GDP, Jobless Claims Higher Than Expected	26/23/26	MT
Ladenburg Thalmann Initiates Coverage on Sonoma Pharmaceuticals at Buy, $3.25 Price Target	05/23/05	MT
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals, Inc. for Reliefacyn Advanced	15/23/15	CI
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Sonoma Pharmaceuticals, Inc. Announces Appointment of Hye Jin Chung to Scientific Advisory Board	03/23/03	CI
Sonoma Pharmaceuticals, Inc. Appoints John Dal Poggetto as Controller	15/23/15	CI
Earnings Flash (SNOA) SONOMA PHARMACEUTICALS Reports Q4 Revenue $3M	22/23/22	MT
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	22/23/22	CI
Sonoma Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	21/23/21	CI
Top Premarket Gainers	09/23/09	MT
Sonoma Pharmaceuticals, Inc. Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union	09/23/09	CI
Sonoma Pharmaceuticals, Inc. Announces CFO Changes	14/23/14	CI
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	15/23/15	CI
Sonoma Pharmaceuticals Signs Distribution Deal With Daewoong Pharmaceutical to Sell Skin Products in South Korea	31/23/31	MT

Chart Sonoma Pharmaceuticals, Inc.

Duration

Period

More charts

Company Profile

Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Sonoma Pharmaceuticals, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3896 USD

Average target price

1.5 USD

Spread / Average Target

+285.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SONOMA PHARMACEUTICALS, INC.	+118.46%	7.4M
ELI LILLY AND COMPANY	+61.92%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.88%	359B
MERCK & CO., INC.	+15.34%	325B
ABBVIE INC.	+9.06%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.91%	177B
PFIZER, INC.	+2.24%	165B

Other Pharmaceuticals